Literature DB >> 26295273

Colorectal cancer screening in the 21st century: where do we go from here?

Jennifer K Maratt, Sameer D Saini1.   

Abstract

Our approach to colorectal cancer screening is undergoing a much-needed paradigm shift. The evidence that screening "works" and is of high value is indisputable, yet screening remains underused at a population level. In contrast, other data suggest overuse of screening. Traditional population-oriented efforts to promote screening utilization have not only failed to adequately address underuse, they have simultaneously promoted overuse of screening in selected groups of patients. Clearly, new approaches are needed if we are to deliver the right care to the right patients at the right time. By shifting our focus from populations to patients, we can aim to achieve the goal set by Healthy People 2020 of ensuring that 70% of the appropriate US population is up-to-date with colorectal cancer screening.

Entities:  

Mesh:

Year:  2015        PMID: 26295273

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  4 in total

1.  Impact of an Episode-Based Payment Initiative by Commercial Payers in Arkansas on Procedure Volume: an Observational Study.

Authors:  Julius L Chen; Michael E Chernew; A Mark Fendrick; Joseph W Thompson; Sherri Rose
Journal:  J Gen Intern Med       Date:  2019-09-16       Impact factor: 5.128

2.  Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.

Authors:  Jean-François Beaulieu; Elizabeth Herring; Shigeru Kanaoka; Éric Tremblay
Journal:  Oncotarget       Date:  2016-03-22

3.  Droplet digital PCR for quantification of ITGA6 in a stool mRNA assay for the detection of colorectal cancers.

Authors:  Elizabeth Herring; Shigeru Kanaoka; Éric Tremblay; Jean-François Beaulieu
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

4.  Integrin α6-Targeted Positron Emission Tomography Imaging of Colorectal Cancer.

Authors:  Yi-Tai Xiao; Chao Zhou; Jia-Cong Ye; Xiao-Chun Yang; Zhi-Jian Li; Xiao-Bin Zheng; Yan Mei; Xin-Ling Li; Wei-Guang Zhang; Wei Fan; Mu-Sheng Zeng; Jian-Jun Li; Guo-Kai Feng
Journal:  ACS Omega       Date:  2019-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.